EUVIMEDEUVIMED entdecken
Übersichtsarbeit

In Utero Therapies, the Next Frontier

Teodora R Kolarova iD, Edith Cheng

American Journal of Medical Genetics Part C: Seminars in Medical Genetics · 2025

DOI: 10.1002/ajmg.c.32135 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2025. Verfasst von Teodora R Kolarova und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Washington, Seattle, Washington, USA. Hauptthemen laut MEDLINE: Fetal Therapies, Prenatal Diagnosis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 48 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Advancements in molecular diagnostics and the expanded understanding of pathophysiologic processes underlying a variety of genetic conditions have led to the design and implementation of many targeted therapies in the past decade. In the prenatal space, these advancements have rapidly changed the field of prenatal diagnosis and have garnered enthusiasm toward interventions aimed at correcting specific disease mechanisms in utero to prevent irreversible injury and/or leverage fetal physiology to increase the effectiveness of these treatments. Although many promising trials are underway, continued efforts to fully elucidate the intricacies of fetal immunology, the fetal blood–brain barrier and precise molecular processes during different stages of development will be paramount to continued refinement of in utero therapies. The social and ethical implications of fetal therapy are also of utmost importance, especially in an era of increasing restrictions on reproductive autonomy. This review aims to summarize current efforts toward in utero targeted fetal therapies as well as the history and ethical implications of such endeavors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fetal TherapiesPrenatal DiagnosisHumansPregnancyFemaleFetus

Stichwörter der Autor:innen

fetal gene therapyin utero enzyme replacement therapyin utero therapyprenatal genetic diagnosis

Autor:innen und Institutionen

  • Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Washington, Seattle, Washington, USA.
  • Division of Medical Genetics, Department of Internal Medicine, University of Washington, Seattle, Washington, USA.

ORCID-Profile: Teodora R Kolarova

Zitieren

APA

Kolarova, T. R., & Cheng, E. (2025). In Utero Therapies, the Next Frontier. American Journal of Medical Genetics Part C: Seminars in Medical Genetics. https://doi.org/10.1002/ajmg.c.32135

Vancouver

Kolarova TR, Cheng E. In Utero Therapies, the Next Frontier. American Journal of Medical Genetics Part C: Seminars in Medical Genetics. 2025. doi:10.1002/ajmg.c.32135

BibTeX
@article{Kolarova2025,
  author = {Kolarova, Teodora R and Cheng, Edith},
  title = {In Utero Therapies, the Next Frontier},
  journal = {American Journal of Medical Genetics Part C: Seminars in Medical Genetics},
  year = {2025},
  doi = {10.1002/ajmg.c.32135}
}
Kostenlos starten →